Within-person reproducibility of proteoforms related to inflammation and renal dysfunction

[1]  S. Dankel,et al.  Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study. , 2021, Clinical nutrition.

[2]  P. Ueland,et al.  Microheterogeneity and preanalytical stability of protein biomarkers of inflammation and renal function. , 2021, Talanta.

[3]  T. Kislinger,et al.  Recent advances in mass spectrometry based clinical proteomics: applications to cancer research , 2020, Clinical Proteomics.

[4]  O. Laterza,et al.  Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography-Tandem Mass Spectrometry: Current State and Future Vision. , 2020, Clinical chemistry.

[5]  E. Fernández,et al.  N-Terminal Proteoforms in Human Disease. , 2020, Trends in biochemical sciences.

[6]  A. Pfeiffer,et al.  In pursuit of novel biomarkers reflecting intestinal inflammation: temporal variability and phenotypic characterisation of serum calprotectin and lactoferrin , 2020 .

[7]  C. Frost,et al.  Reflection on modern methods: calculating a sample size for a repeatability sub-study to correct for measurement error in a single continuous exposure , 2019, International journal of epidemiology.

[8]  P. Ueland,et al.  Multiplex Immuno-MALDI-TOF MS for Targeted Quantification of Protein Biomarkers and Their Proteoforms Related to Inflammation and Renal Dysfunction. , 2018, Analytical chemistry.

[9]  Lloyd M. Smith,et al.  How many human proteoforms are there? , 2018, Nature chemical biology.

[10]  R. Nelson,et al.  Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms , 2016, Proteomes.

[11]  E. Grove,et al.  Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease , 2015, PloS one.

[12]  B. Hedblad,et al.  Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[13]  S. Juraschek,et al.  Within-person variability in high-sensitivity C-reactive protein. , 2012, Archives of internal medicine.

[14]  M. Budoff,et al.  Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. , 2012, Atherosclerosis.

[15]  L. Berglund.  Regression dilution bias: Tools for correction methods and sample size calculation , 2012, Upsala journal of medical sciences.

[16]  C. Y. Wang,et al.  Reliability of Serum Biomarkers of Inflammation from Repeated Measures in Healthy Individuals , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[17]  James F Rusling,et al.  Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. , 2010, The Analyst.

[18]  Mengling Liu,et al.  Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. , 2009, European cytokine network.

[19]  S. Vollset,et al.  Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated , 2008 .

[20]  Gary Walsh,et al.  Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.

[21]  S. Hankinson,et al.  Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis , 2006, Cancer Causes & Control.

[22]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[23]  E. Mannucci,et al.  Cystatin C reference values and aging. , 2006, Clinical biochemistry.

[24]  S. Kagamimori,et al.  Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[25]  H. Boshuizen,et al.  Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[26]  R. Nelson,et al.  Investigating diversity in human plasma proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Reis,et al.  Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[28]  D. Bonett.  Sample size requirements for estimating intraclass correlations with desired precision , 2002, Statistics in medicine.

[29]  G. M. D'eril,et al.  Biological variation of serum amyloid A in healthy subjects. , 2001, Clinical chemistry.

[30]  B. Keevil,et al.  Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. , 1998, Clinical chemistry.

[31]  F. D. de Beer,et al.  Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice , 1996, European journal of clinical investigation.

[32]  I. Kushner,et al.  SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.

[33]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[34]  K. Yoshizaki.  Pathogenic role of IL-6 combined with TNF-α or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases. , 2011, Advances in experimental medicine and biology.

[35]  R. Swaminathan,et al.  Intra-individual variation in creatinine and cystatin C , 2007, Clinical chemistry and laboratory medicine.